Evidence map›Paper›PMID 26068472›Full record

ArticleNucleic acids research2015

SERBP1 affects homologous recombination-mediated DNA repair by regulation of CtIP translation during S phase.

Jang-Won Ahn, Sunjik Kim, Wooju Na, Su-Jin Baek, Jeong-Hwan Kim, Keehong Min, Jeonghun Yeom, Hoyun Kwak, Sunjoo Jeong, Cheolju Lee and 2 more

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 54 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Epigenetic silencing ofEpigenomics · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. TheBiomolecular NMR assignments · 2021
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Jang-Won AhnDepartment of Biological Sciences, Sungkyunkwan University, Suwon 440-746, Republic of Korea.
Sunjik KimDepartment of Biological Sciences, Sungkyunkwan University, Suwon 440-746, Republic of Korea.
Wooju NaDepartment of Biological Sciences, Sungkyunkwan University, Suwon 440-746, Republic of Korea.
Su-Jin BaekHuman Genomics Research Center, KRIBB, Daejeon 305-806, Republic of Korea Department of Functional Genomics, University of Science of Technology, Daejeon 305-350, Republic of Korea.
Jeong-Hwan KimHuman Genomics Research Center, KRIBB, Daejeon 305-806, Republic of Korea.
Keehong MinDepartment of Biological Sciences, Sungkyunkwan University, Suwon 440-746, Republic of Korea.
Jeonghun YeomCenter for Theragnosis, Korea Institute of Science and Technology, Seoul 136-791, Republic of Korea Department of Biological Chemistry, University of Science and Technology, Daejeon 305-333, Republic of Korea.
Hoyun KwakDepartment of Molecular Biology, Dankook University, Yongin 448-701, Republic of Korea.
Sunjoo JeongDepartment of Molecular Biology, Dankook University, Yongin 448-701, Republic of Korea.
Cheolju LeeCenter for Theragnosis, Korea Institute of Science and Technology, Seoul 136-791, Republic of Korea Department of Biological Chemistry, University of Science and Technology, Daejeon 305-333, Republic of Korea.
Seon-Young KimHuman Genomics Research Center, KRIBB, Daejeon 305-806, Republic of Korea Department of Functional Genomics, University of Science of Technology, Daejeon 305-350, Republic of Korea.
Cheol Yong ChoiDepartment of Biological Sciences, Sungkyunkwan University, Suwon 440-746, Republic of Korea choicy@skku.ac.kr.
Sungkyunkwan University · KRDankook University · KRKorea Institute of Science and Technology · KRKorea Research Institute of Bioscience and Biotechnology · KRKorea University of Science and Technology · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

DNA double-strand breaks (DSBs) are the most severe type of DNA damage and are primarily repaired by non-homologous end joining (NHEJ) and homologous recombination (HR) in the G1 and S/G2 phase, respectively. Although CtBP-interacting protein (CtIP) is crucial in DNA end resection during HR following DSBs, little is known about how CtIP levels increase in an S phase-specific manner. Here, we show that Serpine mRNA binding protein 1 (SERBP1) regulates CtIP expression at the translational level in S phase. In response to camptothecin-mediated DNA DSBs, CHK1 and RPA2 phosphorylation, which are hallmarks of HR activation, was abrogated in SERBP1-depleted cells. We identified CtIP mRNA as a binding target of SERBP1 using RNA immunoprecipitation-coupled RNA sequencing, and confirmed SERBP1 binding to CtIP mRNA in S phase. SERBP1 depletion resulted in reduction of polysome-associated CtIP mRNA and concomitant loss of CtIP expression in S phase. These effects were reversed by reconstituting cells with wild-type SERBP1, but not by SERBP1 ΔRGG, an RNA binding defective mutant, suggesting regulation of CtIP translation by SERBP1 association with CtIP mRNA. These results indicate that SERBP1 affects HR-mediated DNA repair in response to DNA DSBs by regulation of CtIP translation in S phase.

Indexed as

Gene Expression RegulationProtein BiosynthesisRecombinational DNA Repair3' Untranslated RegionsAtaxia Telangiectasia Mutated ProteinsCarrier ProteinsCell LineDNA Breaks, Double-StrandedDNA RepairEndodeoxyribonucleasesHeLa CellsHumansNuclear ProteinsRNA-Binding ProteinsRNA, MessengerSignal Transduction3' Untranslated RegionsAtaxia Telangiectasia Mutated ProteinsATR protein, humanCarrier ProteinsEndodeoxyribonucleasesNuclear ProteinsRBBP8 protein, humanRNA-Binding ProteinsRNA, MessengerSERBP1 protein, human

Identifiers

PMID26068472
PMCPMC4513868
OpenAlexW1779460880

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.